Joseph Ramek is an Oncology physician affiliated with North Shore University Hospital. OpenAlex indexes 7 publications with 324 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3003 New Hyde Park Rd
Suite 401
New Hyde Park, NY 110421214
Telephone
516-354-5700Provider last certified this registry record 19 Aug 2025.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Karyopharm Therapeutics Inc.Program year20252 payments
- Janssen Biotech, Inc.Program year20258 payments
- Novartis Pharmaceuticals CorporationProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
87.8%Erythropoiesis-stimulating Agent84.3%Epoetin alfa100%Retacrit1%Part D + Part B<11 patientsFactor Xa inhibitor2.8%Eliquis70%Xarelto30%Part D≥18 patients+ 2 more classes in this area
Cancer & immunology
5.6%Thalidomide Analog1.6%Lenalidomide62%Revlimid38%Part D<11 patientsKinase inhibitor1.5%Brukinsa100%Part D<11 patients+ 4 more classes in this area
Nervous system
2.3%Opioid Agonist1.1%Oxycodone Hcl100%Part D≥11 patientsgamma-Aminobutyric Acid A Receptor Positive Modulator0.8%Zolpidem Tartrate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Fulminant Colitis Following Rituximab Therapy for Disseminated B Cell Marginal Lymphoma
Inflammatory Bowel Diseases
2012 - Fulminant Colitis Following Rituximab Therapy for Disseminated B Cell Marginal Lymphoma
The American Journal of Gastroenterology
2012 - Efficacy of losartan in the treatment of erythrocytosis in a young adult with CRF
Pediatric Nephrology
2003
Similar KOLs
Other experts from the same institution or the same specialty.
David Hirschwerk, MD
North Shore University Hospital
Henry Woo, MD
North Shore University Hospital
Lionel Mailloux, MD
North Shore University Hospital
Shahryar Saba, MD
North Shore University Hospital
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”